Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.
The online learning platform developer spun out of Stanford University priced its shares at the top of their range.
Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.
Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.
The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.
The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.
Tokyo University of Science is set to exit the recruitment services group in an IPO in Tokyo.
Duke University's contactless security system developer agrees to list through a reverse takeover, providing an exit to OUP.